SCINAI IMMUNOTHERAPEUTICS LTD. Investing Cash Flow
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Investing Cash Flow of -$24.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-04-01
- SCINAI IMMUNOTHERAPEUTICS LTD. net cash provided by (used in) investing activities for the quarter ending 2023-06-30 was -$377.00K, a 1177.14% decline year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. net cash provided by (used in) investing activities for the quarter ending 2023-03-31 was -$6.00K.
- SCINAI IMMUNOTHERAPEUTICS LTD. net cash provided by (used in) investing activities for the quarter ending 2022-06-30 was $35.00K.
- SCINAI IMMUNOTHERAPEUTICS LTD. net cash provided by (used in) investing activities for the quarter ending 2022-03-31 was -$521.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|
| 2025-12-31 | -$24.00K 20-F · filed 2026-04-01 | ||
| 2025-06-30 | -$12.00K 6-K · filed 2025-09-02 | ||
| 2024-12-31 | -$12.00K 20-F · filed 2026-04-01 | ||
| 2024-06-30 | -$8.00K 6-K · filed 2025-09-02 | ||
| 2023-12-31 | -$637.00K 20-F · filed 2026-04-01 | ||
| 2023-06-30 | -$377.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-09-09 | -$383.00K 6-K · filed 2024-09-09 | |
| 2023-03-31 | -$6.00K 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | -$836.00K 20-F · filed 2025-05-07 | ||
| 2022-06-30 | $35.00K derived: 6-K/A 6 month − 10-Q 3 month · filed 2023-08-18 | -$486.00K 6-K/A · filed 2023-08-18 | |
| 2022-03-31 | -$521.00K 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | -$139.00K 20-F · filed 2024-05-15 |